The independent source for health policy research, polling, and news.
JAMA Forum: Don’t Be Surprised if the Next Big Health Care Debate Is About Drug Prices
In this post for The JAMA Forum, Larry Levitt examines both the Democratic candidates’ proposals and the Trump administration’s record on lowering drug prices, which remains a top issue for the public with bi-partisan support.
Column Read PostSelf-insured Companies Do No Better on Cost Control
A data surprise? Drew Altman, in his latest Axios column, shows there is no difference between large self-insured and fully insured companies when it comes to controlling health care costs, bucking conventional wisdom.
Column Read PostThe ACA is Doing Fine Without a Mandate Penalty
In an Axios column, Drew Altman explains that the elimination of the Affordable Care Act’s individual mandate penalty has had little impact on how the ACA’s insurance markets are working, showing that “the marketplaces continue to function, even when ‘severed’ from the mandate penalty,” and undercutting a central argument in the lawsuit seeking to strike down the entire law.
Column Read PostHealth Policy in 2020 Will Be Made in the States
With a questionable outlook for 2020 passage of legislation on prescription drug pricing and surprise medical bills, Drew Altman says the real action to watch in health policy is likely to be in the states.
Column Read PostPrivate Insurance’s Costs are Skyrocketing
In this Axios column, Drew Altman takes a long-term view of the recently released federal data on health spending showing that spending for private insurance is rising much faster than for Medicare and Medicaid, and predicts rising pressure in the health care industry as a result.
Column Read PostSurprise Bills Often Hit in Emergencies
In an Axios column, Drew Altman previews new data highlighting that people with critical health issues are especially vulnerable to these bills.
Column Read Post